Plain-English translation of NCT06804278 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new generation of CT scanner called Spectral CT to see if it can better diagnose myocarditis (heart muscle inflammation) and other causes of chest pain. The scanner uses special technology to look more closely at heart tissue than regular CT scanners can. Researchers hope this will help doctors quickly and accurately figure out what's causing chest pain when patients arrive at the hospital.
Right now, doctors struggle to diagnose heart inflammation using standard imaging tools, especially in emergency situations when patients have chest pain. This study aims to fill that gap by testing whether the new scanning technology can reliably detect heart inflammation and distinguish it from other serious conditions like heart attacks.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for a specialized CT scan of your heart as part of your standard chest pain evaluation. The scan uses a new type of imaging technology that takes very detailed pictures of your heart tissue. The scan itself takes only a few minutes, though your overall visit will depend on your hospital's normal procedures for evaluating chest pain.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment target
~200 participants
Started
November 2024
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vincenzo Russo, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.